Navigation Links
PharmaVentures' Client Sanofi Wins Scrip 'Outsourcing Deal of the Year Award'
Date:1/12/2012

OXFORD, English, January 12, 2012 /PRNewswire/ --

PharmaVentures announced today that it was delighted to play an advisory role in the Sanofi - Covance deal which won Scrip's 'Outsourcing Deal of the Year 2011'.

The judges described the deal as 'impressive' as it was "one the largest and most comprehensive R&D alliances in the history of the pharmaceutical and CRO industry".Under the terms of the agreement, Sanofi retains access to some of the capabilities that were divested to Covance as part of a long-term strategic alliance. Covance will provide Sanofi with an up to 10-year sole source relationship for central lab services.

Kevin Bottomley, Head of Transactions at PharmaVentures who was lead advisor to Sanofi on the deal said:  "This is a great recognition for Sanofi as this was a ground-breaking deal which ultimately supports both its overall strategic intent."

Fintan Walton, Chief Executive of PharmaVentures said: "Deal making has become both more complex and more sophisticated. This Scrip Award recognises how PharmaVentures' clients are reaching new heights in deal making. We are delighted to be advisors to this award winning deal."

Over the years PharmaVentures has built considerable experience in the M&A field including divestments of manufacturing and R&D businesses.

Note to Editors

If you wish to write an article, please contact us for any further information you require.

About PharmaVentures

PharmaVentures (http://www.pharmaventures.com) is an international healthcare advisory group providing leadership in all aspects of deals and alliances, from strategy formulations to implementation. The company occupies a special position in the global marketplace because of our track record of successful outcomes, resulting from our unique insight into the world of deal making, our internationally recognised analytical and valuation capabilities, our own proprietary deal making database PharmaDeals®(http://www.pharmadeals.net), containing over 42,000 deal records, and our extensive business relationship network and our outstanding success in M&A transactions.

Our Services Cover:

  • Valuation (for licensing, acquisitions, divestments, fund raising & expert testimonies)
  • Licensing (In and Out licensing)
  • M&A (Companies & Assets)
  • Strategy (commercialisation, deal strategy, due diligence, market entry)
  • Expert Testimony (Patent Infringement, Deal Disagreements, Taxation, Determining Damages)

Now in its 20th year, PharmaVentures is based in Oxford, UK, and employs over 30 people.

PharmaDeals® and PharmaVentures® are registered Trade Marks of PharmaVentures Ltd.

For further information, contact:
Kevin Bottomley
Head of Transactions
+44 1865-332700
Kevin.Bottomley@pharmaventures.com



'/>"/>
SOURCE PharmaVentures Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaVentures Appoints Andy Smith as Head of Corporate Finance
2. PharmaVentures Engaged by Astex Therapeutics to Assist in the Divestment of US Facility
3. Matrix Corporate Capital and PharmaVentures Announce the Signing of a Memorandum of Understanding (MOU)
4. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
5. PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C.F.M. Group
6. Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
7. Netsmart Clients to Receive Nearly $2 Million in Meaningful Use EHR Incentive Payments
8. AquaStar Holdings, Inc.s Client Receives U.S. Patent 7,708,944 for Portable Capillary Sensor Technology
9. Paul Pospisil Joins Korn/Ferry as Senior Client Partner in Biotechnology and Life Sciences Practice
10. Sermo Announces New Client Center with Advanced Mining and Monitoring of Organic Physician Dialog
11. bj-diagnostik Renforce le Conseil-client Pour les Tests ADN de Fratrie et de Paternit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Ky. and HOUSTON ... Inc. ("NX Prenatal") today announced the formation of ... together leading clinicians and industry veterans who enhance ... company as it accelerates development of its novel ... to provide medical, clinical and strategic guidance for ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... software solutions for pharmaceutical research and development (R&D), today announced the launch ... data analysis and interpretation for the rapidly evolving field of precision medicine. ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... , ... January 18, 2017 , ... ... tech innovators, engineers, and scientists from around the world, was today awarded the ... awards program is based entirely on merit and decided upon by a dedicated ...
Breaking Biology Technology:
(Date:1/12/2017)... , January 12, 2017 A new report by Allied ... that the global biometric technology market is expected to generate revenue of $10.72 billion ... Continue Reading ... Allied Market Research ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/6/2017)...  SomaLogic announced today that it has agreed ... iCarbonX, the China -based company ... Health Ecosystem that can define each person,s ,digital ... behavioral and psychological data, the Internet and artificial ... will provide proteomics data and applications expertise to ...
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
Breaking Biology News(10 mins):